Pages that link to "Q48024829"
Jump to navigation
Jump to search
The following pages link to Renal expression of IL-6 and TNFalpha genes in lupus nephritis (Q48024829):
Displaying 50 items.
- Rationale for interleukin-6 blockade in systemic lupus erythematosus (Q24564990) (← links)
- SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus (Q24804939) (← links)
- Mechanisms of Kidney Injury in Lupus Nephritis - the Role of Anti-dsDNA Antibodies (Q26781272) (← links)
- Lupus nephritis: the evolving role of novel therapeutics (Q26998390) (← links)
- Imbalance between interleukin-6 and adrenomedullin mRNA levels in peripheral blood mononuclear cells of patients with lupus nephritis (Q28367606) (← links)
- Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxiphylline (Q32175787) (← links)
- Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update (Q33586501) (← links)
- Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial (Q33731705) (← links)
- Cytokine networks in systemic lupus erythematosus (Q33803103) (← links)
- Cytokines and systemic lupus erythematosus (Q33873329) (← links)
- Genetics of systemic lupus erythematosus. Clinical implications (Q33893349) (← links)
- Anti-TNF-alpha therapies in systemic lupus erythematosus (Q33960066) (← links)
- Update on therapy--thalidomide in the treatment of lupus (Q34227018) (← links)
- Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus (Q34339359) (← links)
- Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis (Q34457056) (← links)
- Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients. (Q34754611) (← links)
- MicroRNA-let-7a expression is increased in the mesangial cells of NZB/W mice and increases IL-6 production in vitro (Q35601698) (← links)
- Cytokine disturbances in systemic lupus erythematosus (Q35617573) (← links)
- HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response. (Q35675014) (← links)
- Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions (Q35724900) (← links)
- Cytokines in the rheumatic diseases (Q35733792) (← links)
- Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention (Q35824493) (← links)
- Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE (Q35829864) (← links)
- The TNFalpha locus is altered in monocytes from patients with systemic lupus erythematosus (Q35867539) (← links)
- Beneficial effect of Bupleurum polysaccharides on autoimmune-prone MRL-lpr mice (Q36023695) (← links)
- The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis (Q36299959) (← links)
- Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN (Q36417899) (← links)
- The role of tumor necrosis factor-alpha in systemic lupus erythematosus (Q36641608) (← links)
- B lymphocytes as therapeutic targets in systemic lupus erythematosus (Q36653646) (← links)
- What is damaging the kidney in lupus nephritis? (Q36765221) (← links)
- TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects (Q37072767) (← links)
- Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis (Q37221965) (← links)
- Immunoregulatory role of TNFalpha in inflammatory kidney diseases (Q37478985) (← links)
- Concentrated fish oil (Lovaza(R)) extends lifespan and attenuates kidney disease in lupus-prone short-lived (NZBxNZW)F1 mice (Q37673404) (← links)
- IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. (Q37730845) (← links)
- Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances (Q37751877) (← links)
- Role of TWEAK in lupus nephritis: a bench-to-bedside review (Q38021183) (← links)
- The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside (Q38085723) (← links)
- Future prospects in biologic therapy for systemic lupus erythematosus (Q38135706) (← links)
- Sirukumab : a novel therapy for lupus nephritis? (Q38246130) (← links)
- Progress with the use of monoclonal antibodies for the treatment of systemic lupus erythematosus (Q38389307) (← links)
- Tolerogenic probiotics: potential immunoregulators in Systemic Lupus Erythematosus. (Q39044374) (← links)
- CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. (Q39855226) (← links)
- MicroRNA Profiling of B Cell Subsets from Systemic Lupus Erythematosus Patients Reveals Promising Novel Biomarkers (Q40678173) (← links)
- Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation (Q41837557) (← links)
- Mycophenolate mofetil in lupus nephritis refractory to intravenous cyclophosphamide (Q42728793) (← links)
- Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus (Q44586795) (← links)
- Up-regulated renal expression of TNF-alpha signalling adapter proteins in lupus glomerulonephritis (Q46158716) (← links)
- NCS 613 exhibits anti-inflammatory effects on PBMCs from lupus patients by inhibiting p38 MAPK and NF-κB signalling pathways while reducing proinflammatory cytokine production (Q46982725) (← links)
- Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus (Q47422803) (← links)